Differential frequency in <scp>imaging‐based</scp> outcome measurement: Bias in <scp>real‐world</scp> oncology <scp>comparative‐effectiveness</scp> studies

Abstract

This study provided evidence that the frequency of imaging assessments to detect disease progression can differ by treatment type in real-world patients with cancer and may induce some bias in comparative-effectiveness studies in some situations.